Investpharma Ltd

All UK companiesOther service activitiesInvestpharma Ltd

Other service activities n.e.c.

Investpharma Ltd contacts: address, phone, fax, email, website, shedule

Address: Suite 1, 5 Percy Street W1T 1DG London

Phone: +44-1452 8687683

Fax: +44-1452 8687683

Email: n\a

Website:

Shedule:

Incorrect data or we want add more details informations for "Investpharma Ltd"? - send email to us!

Investpharma Ltd detailed report: finance, accounts, vacancies. Get credit history, taxes and fees, banks accounts, tenders Investpharma Ltd.

Registration data Investpharma Ltd

Register date: 2012-06-14

Register number: 08105746

Type of company: Private Limited Company

Get full report form global database UK for Investpharma Ltd

Owner, director, manager of Investpharma Ltd

Jennifer Catherine Rene Director. Address: 5 Percy Street, London, W1T 1DG, United Kingdom. DoB: November 1954, British

Jobs in Investpharma Ltd vacancies. Career and practice on Investpharma Ltd. Working and traineeship

Sorry, now on Investpharma Ltd all vacancies is closed.

Responds for Investpharma Ltd on FaceBook

Read more comments for Investpharma Ltd. Leave a respond Investpharma Ltd in social networks. Investpharma Ltd on Facebook and Google+, LinkedIn, MySpace

Address Investpharma Ltd on google map

Other similar UK companies as Investpharma Ltd: Azafran Limited | Grips413 Limited | Pernupro Limited | Haltrecht Charitable Trust | The Foot Parlour Limited

Registered as 08105746 4 years ago, Investpharma Ltd is categorised as a Private Limited Company. The business present office address is Suite 1,, 5 Percy Street London. The company SIC code is 96090 which stands for Other service activities not elsewhere classified. The business latest filed account data documents were submitted for the period up to 2015/06/30 and the latest annual return information was filed on 2015/06/17. Right from the moment it was started four years ago, the company has been a reference point for others in this field, achieving their business goals.

In the firm, just about all of director's responsibilities have so far been done by Jennifer Catherine Rene who was selected to lead the company in 2012.